JG
NUVB icon

Joel Greenblatt’s Nuvation Bio NUVB Stock Holding History

Joel Greenblatt’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
+182,152
New +$890K ﹤0.01% 1350
2026
Q1 		– Sell
-31,269
Closed -$280K – 1830
2025
Q4 		$280K Buy
31,269
+14,204
+83% +$88K ﹤0.01% 1583
2025
Q3 		$63.1K Buy
+17,065
New +$46.5K ﹤0.01% 1663

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Joel Greenblatt's NUVB Position: Q2 2026 in Review

Joel Greenblatt opened a new position in Nuvation Bio (NUVB) in Q2 2026: 182,152 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #1350 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in NUVB as recently as Q4 2025.

Joel Greenblatt first reported a position in NUVB in Q3 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Joel Greenblatt held 182,152 shares of Nuvation Bio worth $1.03M as of Q2 2026.
  • Nuvation Bio was a new Joel Greenblatt position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1350 holding.
  • Joel Greenblatt first reported a position in Nuvation Bio in Q3 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.